Cardiovascular-related deaths at the beginning of the COVID-19 outbreak : A prospective analysis based on the UK Biobank

dc.contributor.authorWang, Junren
dc.contributor.authorZhu, Jianwei
dc.contributor.authorYang, Huazhen
dc.contributor.authorHu, Yao
dc.contributor.authorSun, Yajing
dc.contributor.authorYing, Zhiye
dc.contributor.authorQu, Yuanyuan
dc.contributor.authorValdimarsdottir, Unnur
dc.contributor.authorFang, Fang
dc.contributor.authorSong, Huan
dc.contributor.departmentFaculty of Medicine
dc.date.accessioned2025-11-20T08:18:32Z
dc.date.available2025-11-20T08:18:32Z
dc.date.issued2021-06-04
dc.descriptionFunding Information: Funding This work is supported by the National Science Foundation of China (No. 81971262 to HS), West China Hospital COVID-19 Epidemic Science and Technology Project (No. HX-2019-nCoV-014 to HS), Sichuan University Emergency Grant (No. 2020scunCoVyingji10002 to HS), EU Horizon2020 Research and Innovation Action Grant (847776 to UV and FF) and NordForsk grant (105668 to UV and FF). Publisher Copyright: ©en
dc.description.abstractObjective To assess the impact of the COVID-19 outbreak on cardiovascular disease (CVD) related mortality and hospitalisation. Design Community-based prospective cohort study. Setting The UK Biobank. Participants 421 372 UK Biobank participants who were registered in England and alive as of 1 January 2020. Primary and secondary outcome measures The primary outcome of interest was CVD-related death, which was defined as death with CVD as a cause in the death register. We retrieved information on hospitalisations with CVD as the primary diagnosis from the UK Biobank hospital inpatient data. The study period was 1 January 2020 to June 30 2020, and we used the same calendar period of the three preceding years as the reference period. In order to control for seasonal variations and ageing of the study population, standardised mortality/incidence ratios (SMRs/SIRs) with 95% CIs were used to estimate the relative risk of CVD outcomes during the study period, compared with the reference period. Results We observed a distinct increase in CVD-related deaths in March and April 2020, compared with the corresponding months of the three preceding years. The observed number of CVD-related deaths (n=218) was almost double in April, compared with the expected number (n=120) (SMR=1.82, 95% CI 1.58 to 2.07). In addition, we observed a significant decline in CVD-related hospitalisations from March onwards, with the lowest SIR observed in April (0.45, 95% CI 0.41 to 0.49). Conclusions There was a distinct increase in the number of CVD-related deaths in the UK Biobank population at the beginning of the COVID-19 outbreak. The shortage of medical resources for hospital care and stress reactions to the pandemic might have partially contributed to the excess CVD-related mortality, underscoring the need of sufficient healthcare resources and improved instructions to the public about seeking healthcare in a timely way.en
dc.description.versionPeer revieweden
dc.format.extent782797
dc.format.extente046931
dc.identifier.citationWang, J, Zhu, J, Yang, H, Hu, Y, Sun, Y, Ying, Z, Qu, Y, Valdimarsdottir, U, Fang, F & Song, H 2021, 'Cardiovascular-related deaths at the beginning of the COVID-19 outbreak : A prospective analysis based on the UK Biobank', BMJ Open, vol. 11, no. 6, e046931, pp. e046931. https://doi.org/10.1136/bmjopen-2020-046931en
dc.identifier.doi10.1136/bmjopen-2020-046931
dc.identifier.issn2044-6055
dc.identifier.other36345551
dc.identifier.othere269fbed-c301-4038-913e-12fde3efbfae
dc.identifier.other85107776174
dc.identifier.other34088708
dc.identifier.urihttps://hdl.handle.net/20.500.11815/6259
dc.language.isoen
dc.relationinfo:eu-repo/grantAgreement/EC/FH2020/
dc.relation.ispartofseriesBMJ Open; 11(6)en
dc.relation.urlhttps://www.scopus.com/pages/publications/85107776174en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.subjectcardiologyen
dc.subjectCOVID-19en
dc.subjectepidemiologyen
dc.subjecthealth services administration & managementen
dc.subjectSARS-CoV-2en
dc.subjectProspective Studiesen
dc.subjectDisease Outbreaksen
dc.subjectBiological Specimen Banksen
dc.subjectHumansen
dc.subjectRisk Factorsen
dc.subjectEngland/epidemiologyen
dc.subjectUnited Kingdom/epidemiologyen
dc.subjectGeneral Medicineen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subject847776en
dc.titleCardiovascular-related deaths at the beginning of the COVID-19 outbreak : A prospective analysis based on the UK Biobanken
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/articleen

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Nafn:
e046931.full.pdf
Stærð:
764.45 KB
Snið:
Adobe Portable Document Format

Undirflokkur